Litigation

Recent Posts

Jury Awards $9B In 1st MDL Actos Bladder Cancer Trial Against Takeda, Eli Lilly
Posted on 8 Apr 2014 by Tom Moylan

LAFAYETTE, La. — (Mealey’s) The first federal court Actos bladder cancer trial ended April 7 in a $9 billion verdict against co-defendants Takeda Pharmaceuticals USA Inc. and Eli Lilly & Co. Inc., according to Takeda ( In Re: Actos [Pioglitazone... Read More

Maryland Jury Awards $1.7 Million In 2nd Actos Bladder Cancer Case
Posted on 26 Sep 2013 by Tom Moylan

BALTIMORE — (Mealey’s) A Maryland state court jury on Sept. 26 awarded $1.76 million in the second Actos bladder cancer case to go to trial ( An v. Takeda Pharmaceuticals America, Inc. , No. 24-C12003565, Md. Cir., Baltimore City). ( Verdict... Read More

No New Trial In Actos MDL Bellwether Case, But Punitives Are Cut From $9 Billion To $36 Million
Posted on 29 Oct 2014 by Tom Moylan

LAFAYETTE, La. — (Mealey’s) Takeda Pharmaceutical Co. Ltd. and Eli Lilly and Co. will not get a new trial in the first Actos bladder cancer multidistrict litigation bellwether case, but a Louisiana federal judge on Oct. 27 reduced the $9 billion... Read More

California Appeals Court Reinstates $6.5 Million Actos Verdict; Expert Back In
Posted on 17 Jul 2015 by Tom Moylan

LOS ANGELES — (Mealey’s) A California appeals court panel on July 16 reinstated a $6.5 million Actos bladder cancer verdict, finding that the trial court erred in excluding the plaintiffs’ causation expert in a post-verdict ruling (... Read More

Takeda To Pay Up To $2.4 Billion To Settle About 9,000 Actos Bladder Cancer Claims
Posted on 29 Apr 2015 by Tom Moylan

LAFAYETTE, La. — (Mealey’s) Takeda Pharmaceutical Co. Ltd. will pay up to $2.4 billion to settle the “vast majority” of Actos bladder cancer lawsuits in the United States, the company, plaintiff attorneys and the multidistrict... Read More

Pennsylvania State Court Jury Awards Plaintiff $2 Million In Actos Bladder Cancer Case
Posted on 6 Oct 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) A Pennsylvania state court jury on Oct. 3 awarded an Actos bladder cancer patient $2.05 million in economic and noneconomic damages but declined to award punitive damages ( Frances Wisniewski v. Takeda Pharmaceuticals... Read More

Illinois Jury Finds For Takeda In Actos Bladder Cancer Trial
Posted on 16 May 2014 by Tom Moylan

CHICAGO — (Mealey’s) An Illinois state court jury on May 15 returned a defense verdict in an Actos bladder cancer death case after four weeks of testimony ( In Re: Actos Litigation , No. 11 L 010011, Diane Whitlatch, et al. v. Takeda Pharmaceuticals... Read More

W.Va. Jury Finds Spoliation Of Evidence, Awards $155,000 Against Actos Manufacturer Takeda
Posted on 18 Nov 2014 by Tom Moylan

MARTINSBURG, W.Va. — (Mealey’s) A West Virginia state court jury on Nov. 17 found that Actos is not unsafe and that manufacturer Takeda Pharmaceutical Co. Ltd. was not negligent in the case of a man who developed bladder cancer while taking... Read More

Nevada State Court Jury Returns Defense Verdict In 2-Plaintiff Actos Cancer Trial
Posted on 23 May 2014 by Tom Moylan

LAS VEGAS — (Mealey's) A Nevada state court jury on May 22 returned a unanimous defense verdict in a 32-day, two-plaintiff Actos bladder cancer trial, but two plaintiff attorneys say they will seek a new trial because they believe their objections... Read More

California State Jury Awards $6.5 Million In 1st Actos Bladder Cancer Case To Go To Trial
Posted on 29 Apr 2013 by Tom Moylan

LOS ANGELES - (Mealey's) A California state court jury on April 26 awarded $6.5 million in the first Actos bladder cancer case to go to trial, according to the parties ( Jack Cooper v. Takeda Pharmaceuticals America Inc. , CGC-12-518535, Calif. Super... Read More

Lawsuits Follow Diabetes Drug Actos' Link To Cancer Risk
Posted on 9 Aug 2011 by LexisNexis Litigation Resource Community Staff

TRENTON, N.J. - (AP) The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer. In June, Takeda Pharmaceuticals... Read More